Emergent’s OTC Naloxone Single-Panel Instruction List Prompts Doubletake From US FDA Officials

Larger box “would accommodate all five steps on the single back panel,” says Emergent executive Manish Vyas. But FDA says proposed DFl for OTC Narcan nasal spray “has not yet been officially submitted or reviewed.”